Exhibit 99.1 EvtoSorbents WORKING TO SAVE LIVES CytoSorbents Reports Third Quarter 2024 Financial and Operational Results PRINCETON, N.J., November 7, 2024 — CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, today reported unaudited financial and operating results for the third quarter ended September 30, 2024. Third Quarter 2024 Financial Results · Product revenue of $8.6 million, 11% gr ...